Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Neurotrope, Inc. | v461285_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Neurotrope, Inc. | v461285_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Neurotrope, Inc. | v461285_ex31-1.htm |
| EX-14.1 - EXHIBIT 14.1 - Neurotrope, Inc. | v461285_ex14-1.htm |
| EX-10.34 - EXHIBIT 10.34 - Neurotrope, Inc. | v461285_ex10-34.htm |
| EX-10.33 - EXHIBIT 10.33 - Neurotrope, Inc. | v461285_ex10-33.htm |
| EX-3.1 - EXHIBIT 3.1 - Neurotrope, Inc. | v461285_ex3-1.htm |
| 10-K - FORM 10-K - Neurotrope, Inc. | v461285_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-215159, 333-200664 and 333-208502) and on Form S-8 (No. 333-200310) of Neurotrope, Inc. of our report dated March 10, 2017 relating to the consolidated financial statements of Neurotrope, Inc., which appear in this Form 10-K.
/s/ Friedman LLP
East Hanover, New Jersey
March 10, 2017